Jane Street’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $146K | Sell |
31,165
-789,057
| -96% | -$3.68M | ﹤0.01% | 4882 |
|
|
2025
Q1 | $4.5M | Buy |
820,222
+513,977
| +168% | +$2.82M | ﹤0.01% | 1466 |
|
|
2024
Q4 | $1.04M | Sell |
306,245
-12,515
| -4% | -$42.4K | ﹤0.01% | 2900 |
|
|
2024
Q3 | $908K | Sell |
318,760
-28,832
| -8% | -$82.2K | ﹤0.01% | 3526 |
|
|
2024
Q2 | $782K | Buy |
347,592
+117,634
| +51% | +$265K | ﹤0.01% | 4006 |
|
|
2024
Q1 | $508K | Buy |
229,958
+6,374
| +3% | +$14.1K | ﹤0.01% | 4026 |
|
|
2023
Q4 | $525K | Buy |
223,584
+79,980
| +56% | +$188K | ﹤0.01% | 4046 |
|
|
2023
Q3 | $267K | Buy |
143,604
+17,189
| +14% | +$32K | ﹤0.01% | 4167 |
|
|
2023
Q2 | $331K | Sell |
126,415
-9,407
| -7% | -$24.6K | ﹤0.01% | 4162 |
|
|
2023
Q1 | $221K | Sell |
135,822
-45,740
| -25% | -$74.6K | ﹤0.01% | 4595 |
|
|
2022
Q4 | $241K | Buy |
181,562
+63,964
| +54% | +$85.1K | ﹤0.01% | 4205 |
|
|
2022
Q3 | $183K | Sell |
117,598
-148,698
| -56% | -$231K | ﹤0.01% | 4633 |
|
|
2022
Q2 | $410K | Sell |
266,296
-196,583
| -42% | -$303K | ﹤0.01% | 3766 |
|
|
2022
Q1 | $1.19M | Buy |
462,879
+349,469
| +308% | +$895K | ﹤0.01% | 2742 |
|
|
2021
Q4 | $332K | Buy |
113,410
+97,476
| +612% | +$285K | ﹤0.01% | 3902 |
|
|
2021
Q3 | $39K | Sell |
15,934
-14,660
| -48% | -$35.9K | ﹤0.01% | 4946 |
|
|
2021
Q2 | $125K | Sell |
30,594
-20,325
| -40% | -$83K | ﹤0.01% | 4675 |
|
|
2021
Q1 | $230K | Buy |
50,919
+25,495
| +100% | +$115K | ﹤0.01% | 4164 |
|
|
2020
Q4 | $125K | Buy |
+25,424
| New | +$125K | ﹤0.01% | 3593 |
|